Completed × Squamous Cell Carcinoma of Head and Neck × Radiotherapy, Intensity-Modulated × Clear all Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
Phase 2 Completed
106 enrolled 12 charts
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy
Phase 2 Completed
67 enrolled 16 charts
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Phase 2 Completed
81 enrolled 18 charts
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Phase 2/3 Completed
196 enrolled 31 charts
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Phase 3 Completed
987 enrolled 59 charts
Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
Phase 1 Completed
2 enrolled
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
Phase 2 Completed
115 enrolled 18 charts
APA
Phase 2 Completed
96 enrolled 34 charts
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
Phase 2 Completed
45 enrolled 22 charts
Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
Phase 2 Completed
62 enrolled 15 charts
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Phase 2 Completed
195 enrolled 19 charts
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
320 enrolled 13 charts
Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer
Phase 1 Completed
19 enrolled
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
Phase 1 Completed
40 enrolled
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
940 enrolled 19 charts
Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Phase 1 Completed
37 enrolled
Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer
Phase 1 Completed
9 enrolled
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
37 enrolled 9 charts
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Completed
20 enrolled 17 charts
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
Completed
3 enrolled
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Phase 2 Completed
26 enrolled
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
44 enrolled 9 charts
Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck
Phase 1 Completed
34 enrolled
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
Phase 2 Completed
40 enrolled
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Completed
20 enrolled
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Phase 1 Completed
48 enrolled
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
Phase 1 Completed
46 enrolled
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
Phase NA Completed
40 enrolled